Obalon Announces Upcoming Conference Presentations

SAN DIEGO, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that Andy Rasdal, Chief Executive Officer, and Bill Plovanic, Chief Financial Officer of Obalon, will present at the following upcoming investor conferences: 

Canaccord Genuity Medical Technologies & Diagnostics ForumThursday, November 9, 2017, Presentation at 2:30pm ESTWestin Grand Central HotelWebcast Available at: http://wsw.com/webcast/canaccord28/obln/

Stifel Healthcare ConferenceTuesday, November 14, 2017, Presentation at 8:45am ESTLotte New York Palace HotelWebcast Available at: http://wsw.com/webcast/stifel10/obln/

Live audio webcasts of the presentation can be accessed through the links above. Replays of the webcasts will be available for 90 days following each presentation.

About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ: OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit www.obalon.com.

For Obalon Therapeutics, Inc.

Investor Contact: William Plovanic Chief Financial Officer Obalon Therapeutics, Inc. Office: +1 760 607 5103 [email protected]

Media: Megan Driscoll EvolveMKD Office Phone: +1 646 517 4220 [email protected]

Source: Obalon Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In